International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 2
March-April 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Artificial Intelligence and Machine Learning in Drug Discovery: Transformative Applications and Interdisciplinary Integration with Nanotechnology and Robotics

Author(s) Mr. Vaibhav Pandey
Country India
Abstract Artificial intelligence (AI) and machine learning (ML) are revolutionizing pharmaceutical research by addressing the persistent challenges of traditional drug discovery, including high costs, lengthy development timelines, and low success rates. This comprehensive review examines the transformative applications of AI/ML across the entire drug discovery pipeline, from target identification to clinical development, while exploring critical interdisciplinary integrations with nanotechnology and robotics. Through systematic analysis of recent advances, we evaluate diverse AI techniques including deep learning, graph neural networks, generative models, and transformers in key areas such as molecular design, lead optimization, ADMET prediction, and clinical trial optimization. The integration of AI with nanotechnology has enabled precise design of nanocarriers for targeted drug delivery, while robotics automation has enhanced high-throughput screening and manufacturing quality control. Despite significant progress, challenges persist in data quality, model interpretability, regulatory frameworks, and ethical considerations. This review synthesizes current applications, identifies critical gaps, and proposes future directions for responsible AI implementation, emphasizing the potential for AI-driven approaches to create safer, more effective, and accessible medicines while maintaining ethical standards and regulatory compliance
Keywords artificial intelligence, machine learning, drug discovery, nanotechnology, robotics, pharmaceuticalresearch, clinical trials
Field Medical / Pharmacy
Published In Volume 7, Issue 5, September-October 2025
Published On 2025-10-09
DOI https://doi.org/10.36948/ijfmr.2025.v07i05.57130
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals